Oral nystatin prophylaxis to prevent systemic fungal infection in very low birth weight preterm infants: A randomized controlled trial

Systemic fungal infection (SFI) is one of leading causes of morbidity and mortality in very low birth weight (VLBW) preterm infants. Because early diagnosis of SFI is challenging due to nonspecific manifestations, prophylaxis becomes crucial.